Echocardiographic Markers and Outcomes in End-Stage Liver Disease
Journal of Clinical Medicine · 07.04.2026 · 15 (7) · 2791
DOI: 10.3390/jcm15072791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 07.04.2026. Verfasst von Teodora Radu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Institute for Cardiovascular Diseases "Prof. Dr. C.C. Iliescu", 022328 Bucharest, Romania. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In end-stage liver disease (ESLD), cardiovascular changes are frequent and relate to the presence of hyperdynamic circulation. In 2019, diagnostic criteria for cirrhotic cardiomyopathy (CCM) were updated to include tissue Doppler and speckle tracking imaging in defining left ventricle (LV) systolic and diastolic dysfunction. Evaluation of diastolic function remains challenging, with frequent indeterminate cases and emerging evidence of worse prognosis. The aim of the present study was to evaluate the prevalence of LV systolic and diastolic dysfunction in cirrhosis, in correlation with liver disease severity and potential prognostic implications.
Methods
We performed an observational, retrospective, non-randomized, single-center study that included 99 cirrhotic patients evaluated for liver transplant (LT) in a tertiary center. Liver disease severity and complications were analyzed with survival and echocardiography data to determine potential correlations with prognosis. For statistical analysis, IBM® SPSS® Statistics version 20 (Chicago, IL, USA) was utilized. A two-sided p-value < 0.05 was considered statistically significant.
Results
Left atrial (LA) volume index (r = 0.230, p = 0.022), LA reservoir strain (r = 0.291, p = 0.003), and LA contraction strain absolute value (r = 0.223, p = 0.027) positively correlated with the severity of liver disease expressed by MELD Na score. LA dilation (≥34 mL/m2) was the most common echocardiographic finding. It was present in 69.7% of patients, with one third having severe LA dilation (>45 mL/m2), which was associated with worse survival (log rank p = 0.019). LA contraction strain with an absolute value higher than 16% was also associated with worse survival (log rank p = 0.024). In multivariable Cox analysis, only MELD-Na and LA volume index remained independently associated with mortality. Diastolic dysfunction appeared more prevalent among the non-surviving patients irrespective of the diagnostic criteria used (p = 0.023 for American Society of Echocardiography 2016 criteria; p = 0.032 for CCM 2019 criteria). On binomial logistic regression, the presence of significant diastolic dysfunction (>grade 1) was associated with an increased probability of composite end-point of death or LT in the presence of liver disease severity confounders. The use of the LA stiffness index in discerning diastolic function in patients with standard inconclusive evaluation may warrant further investigation.
Conclusions
Echocardiographic alterations, particularly LA enlargement, are associated with liver disease severity and clinical outcomes in ESLD. These findings are hypothesis-generating and suggest a potential role for echocardiography in risk stratification, warranting validation in larger prospective studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Emergency Institute for Cardiovascular Diseases "Prof. Dr. C.C. Iliescu", 022328 Bucharest, Romania.
- "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
- Fundeni Clinical Institute, 022328 Bucharest, Romania.
ORCID-Profile: Speranta Maria Iacob
Zitieren
APA
Radu, T., Iacob, S. M., & Gheorghe, L. (2026). Echocardiographic Markers and Outcomes in End-Stage Liver Disease. Journal of Clinical Medicine, 15(7), 2791. https://doi.org/10.3390/jcm15072791
Vancouver
Radu T, Iacob SM, Gheorghe L. Echocardiographic Markers and Outcomes in End-Stage Liver Disease. Journal of Clinical Medicine. 2026;15(7):2791. doi:10.3390/jcm15072791
BibTeX
@article{Radu2026,
author = {Radu, Teodora and Iacob, Speranta Maria and Gheorghe, Liliana},
title = {Echocardiographic Markers and Outcomes in End-Stage Liver Disease},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {7},
pages = {2791},
doi = {10.3390/jcm15072791}
}
EUVIMED